I know for a fact Martin Rogers bought over a million shares at around 4c before he joined the board as he liked the company and it's product suite. He has put more money in with the recent capital raising and options rights issue as has MJ.
So you need to do some more research malmanu b4 getting too down on the investment opportunity available here.
As for the trial tests, my understanding was that the second lot of trials were not conducted properly by the previous management so further testing is being conducted to properly evaluate the true benefits of the product.
Just call the MD and get a true update for yourself.
CGP Price at posting:
3.8¢ Sentiment: Buy Disclosure: Held